Trial Profile
Gadolinium Retention in Human Bone Tissue in Pediatric Patients: A Comparison of Dotarem Versus MultiHance MRI Contrast Agents
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2023
Price :
$35
*
At a glance
- Drugs Gadobenic acid (Primary) ; Gadoterate-meglumine (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- 11 May 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.
- 11 May 2023 Planned primary completion date changed from 1 Mar 2023 to 1 Jun 2024.
- 08 Nov 2022 Planned End Date changed from 1 Oct 2022 to 1 Jun 2023.